Want to see IN:GUFICBIO full AI Analyst Report?
Total Valuation
Gufic Biosciences Limited has a market cap or net worth of ₹39.30B. The enterprise value is ₹40.03B.
Market Cap₹39.30B
Enterprise Value₹40.03B
Share Statistics
Gufic Biosciences Limited has 100,282,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding100,282,510
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Gufic Biosciences Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 8.06%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)8.06%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee6.33M
Profits Per Employee430.68K
Employee Count1,491
Asset Turnover0.70
Inventory Turnover1.86
Valuation Ratios
The current PE Ratio of Gufic Biosciences Limited is 62.5. Gufic Biosciences Limited’s PEG ratio is -5.32.
PE Ratio62.5
PS Ratio2.91
PB Ratio4.13
Price to Fair Value4.13
Price to FCF-152.53
Price to Operating Cash Flow68.01
PEG Ratio-5.32
Income Statement
In the last 12 months, Gufic Biosciences Limited had revenue of 9.44B and earned 642.15M in profits. Earnings per share was 6.40.
Revenue9.44B
Gross Profit3.40B
Operating Income1.21B
Pretax Income865.49M
Net Income642.15M
EBITDA1.54B
Earnings Per Share (EPS)6.40
Cash Flow
In the last 12 months, operating cash flow was 591.15M and capital expenditures -156.33M, giving a free cash flow of 434.82M billion.
Operating Cash Flow591.15M
Free Cash Flow434.82M
Free Cash Flow per Share4.34
Dividends & Yields
Gufic Biosciences Limited pays an annual dividend of ₹0.1, resulting in a dividend yield of 0.03%
Dividend Per Share₹0.1
Dividend Yield0.03%
Payout Ratio1.76%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change13.28%
50-Day Moving Average342.65
200-Day Moving Average327.31
Relative Strength Index (RSI)62.55
Average Volume (3m)2.36K
Important Dates
Gufic Biosciences Limited upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 29, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Gufic Biosciences Limited as a current ratio of 1.55, with Debt / Equity ratio of 60.87%
Current Ratio1.55
Quick Ratio0.92
Debt to Market Cap0.14
Net Debt to EBITDA2.13
Interest Coverage Ratio3.29
Taxes
In the past 12 months, Gufic Biosciences Limited has paid 223.36M in taxes.
Income Tax223.36M
Effective Tax Rate0.26
Enterprise Valuation
Gufic Biosciences Limited EV to EBITDA ratio is 19.97, with an EV/FCF ratio of -170.77.
EV to Sales3.26
EV to EBITDA19.97
EV to Free Cash Flow-170.77
EV to Operating Cash Flow233.53
Balance Sheet
Gufic Biosciences Limited has ₹762.17M in cash and marketable securities with ₹4.05B in debt, giving a net cash position of -₹3.29B billion.
Cash & Marketable Securities₹762.17M
Total Debt₹4.05B
Net Cash-₹3.29B
Net Cash Per Share-₹32.76
Tangible Book Value Per Share₹65.66
Margins
Gross margin is 45.47%, with operating margin of 12.77%, and net profit margin of 6.80%.
Gross Margin45.47%
Operating Margin12.77%
Pretax Margin9.17%
Net Profit Margin6.80%
EBITDA Margin16.31%
EBIT Margin13.05%
Analyst Forecast
The average price target for Gufic Biosciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast15.15%
EPS Growth Forecast-7.86%